Raymond James Financial Services Advisors, Inc. Regeneron Pharmaceuticals, Inc. Transaction History

Raymond James Financial Services Advisors, Inc.

  • $73.5 Billion
  • Q3 2024

A detailed history of Raymond James Financial Services Advisors, Inc. transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Raymond James Financial Services Advisors, Inc. holds 8,297 shares of REGN stock, worth $6.28 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
8,297
Previous 8,044 3.15%
Holding current value
$6.28 Million
Previous $8.45 Million 3.17%
% of portfolio
0.01%
Previous 0.01%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 18, 2024
BUY
$1024.09 - $1201.76 $259,094 - $304,045
253 Added 3.15%
8,297 $8.72 Million
Q2 2024

Jul 19, 2024
SELL
$883.2 - $1071.19 $541,401 - $656,639
-613 Reduced 7.08%
8,044 $8.45 Million
Q1 2024

Apr 22, 2024
SELL
$902.69 - $993.35 $103,809 - $114,235
-115 Reduced 1.31%
8,657 $8.33 Million
Q4 2023

Jan 16, 2024
BUY
$775.18 - $881.7 $295,343 - $335,927
381 Added 4.54%
8,772 $7.7 Million
Q3 2023

Oct 24, 2023
BUY
$692.45 - $844.37 $29,082 - $35,463
42 Added 0.5%
8,391 $6.91 Million
Q2 2023

Jul 25, 2023
SELL
$700.03 - $830.35 $21,700 - $25,740
-31 Reduced 0.37%
8,349 $6 Million
Q1 2023

Apr 14, 2023
SELL
$680.49 - $826.97 $1.13 Million - $1.37 Million
-1,658 Reduced 16.52%
8,380 $6.89 Million
Q4 2022

Feb 08, 2023
SELL
$705.89 - $766.39 $309,885 - $336,445
-439 Reduced 4.19%
10,038 $7.24 Million
Q3 2022

Oct 25, 2022
SELL
$573.97 - $724.32 $773,711 - $976,383
-1,348 Reduced 11.4%
10,477 $7.22 Million
Q2 2022

Aug 12, 2022
SELL
$548.35 - $738.84 $607,571 - $818,634
-1,108 Reduced 8.57%
11,825 $6.99 Million
Q1 2022

May 11, 2022
SELL
$595.12 - $698.43 $2.88 Million - $3.38 Million
-4,842 Reduced 27.24%
12,933 $9.03 Million
Q4 2021

Feb 08, 2022
BUY
$543.48 - $670.97 $1.25 Million - $1.55 Million
2,308 Added 14.92%
17,775 $11.2 Million
Q3 2021

Nov 02, 2021
SELL
$574.03 - $680.96 $181,393 - $215,183
-316 Reduced 2.0%
15,467 $9.36 Million
Q2 2021

Aug 11, 2021
BUY
$472.8 - $558.54 $940,872 - $1.11 Million
1,990 Added 14.43%
15,783 $8.82 Million
Q1 2021

May 14, 2021
BUY
$446.73 - $548.2 $1.89 Million - $2.32 Million
4,235 Added 44.31%
13,793 $6.53 Million
Q4 2020

Feb 12, 2021
BUY
$478.3 - $607.98 $76,049 - $96,668
159 Added 1.69%
9,558 $4.62 Million
Q3 2020

Nov 04, 2020
SELL
$544.75 - $658.21 $3.96 Million - $4.79 Million
-7,277 Reduced 43.64%
9,399 $5.26 Million
Q2 2020

Jul 17, 2020
BUY
$493.32 - $643.92 $3.89 Million - $5.08 Million
7,891 Added 89.82%
16,676 $10.4 Million
Q1 2020

Apr 21, 2020
BUY
$336.18 - $494.43 $351,644 - $517,173
1,046 Added 13.52%
8,785 $4.29 Million
Q4 2019

Feb 12, 2020
BUY
$274.13 - $376.51 $135,420 - $185,995
494 Added 6.82%
7,739 $2.91 Million
Q3 2019

Nov 07, 2019
SELL
$273.46 - $318.39 $91,335 - $106,342
-334 Reduced 4.41%
7,245 $2.01 Million
Q2 2019

Aug 06, 2019
BUY
$299.6 - $414.82 $833,487 - $1.15 Million
2,782 Added 57.99%
7,579 $2.37 Million
Q1 2019

May 06, 2019
BUY
$372.08 - $439.57 $261,572 - $309,017
703 Added 17.17%
4,797 $1.97 Million
Q4 2018

Feb 11, 2019
BUY
$335.82 - $403.04 $255,894 - $307,116
762 Added 22.87%
4,094 $1.53 Million
Q3 2018

Nov 14, 2018
BUY
$351.14 - $408.51 $66,014 - $76,799
188 Added 5.98%
3,332 $1.35 Million
Q2 2018

Jul 30, 2018
BUY
$284.6 - $344.99 $40,128 - $48,643
141 Added 4.7%
3,144 $1.09 Million
Q1 2018

Apr 16, 2018
BUY
$315.82 - $393.78 $74,533 - $92,932
236 Added 8.53%
3,003 $1.03 Million
Q4 2017

Feb 09, 2018
SELL
$358.63 - $469.95 $30,124 - $39,475
-84 Reduced 2.95%
2,767 $1.04 Million
Q3 2017

Oct 26, 2017
SELL
$431.38 - $504.0 $155,728 - $181,944
-361 Reduced 11.24%
2,851 $1.28 Million
Q2 2017

Aug 15, 2017
BUY
N/A
3,212
3,212 $1.58 Million

Others Institutions Holding REGN

# of Institutions
1,529
Shares Held
84.1M
Call Options Held
1.22M
Put Options Held
1.51M
View Full List

About REGENERON PHARMACEUTICALS, INC.

REGN Quotes by TradingView
  • Ticker REGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 107,190,000
  • Market Cap $81.1B
  • Description
  • Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...
More about REGN
Track This Portfolio

Track Raymond James Financial Services Advisors, Inc. Portfolio

Follow Raymond James Financial Services Advisors, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Raymond James Financial Services Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Raymond James Financial Services Advisors, Inc. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email